Results for "genetic disorder"
Conditions Encyclopedia Entry 1776619565
Cystic fibrosis (CF) is a chronic, genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and potentially life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1776509171
Cystic fibrosis is a chronic, progressive genetic disorder that affects the respiratory, digestive, and reproductive systems, causing thick, sticky mucus buildup and life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1776225252
Cystic fibrosis (CF) is a chronic, genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and early death if left untreated.
Health & MedicineConditions Encyclopedia Entry 1775992569
** **Cystic Fibrosis** is a chronic, genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and early death if left untreated. **CONTENT:** ### Overview Cystic Fibrosis (CF) is a complex, life-threatening disease that affects approximately 70,000 people in the United States and over 75,000 worldwide. It is caused by mutations in the **CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene**, which codes for a protein responsible for regulating the movement of salt and water in and out of cells. In individuals with CF, the defective protein leads to the production of thick, sticky mucus that clogs the airways, digestive tract, and other organs, causing a range of symptoms and complications. CF is an autosomal recessive disorder, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition. Carriers of the mutated gene, who have one normal and one mutated copy, are generally asymptomatic but can pass the mutated gene to their offspring. The disease is characterized by a range of symptoms, including persistent coughing, wheezing, and shortness of breath, as well as digestive problems, such as abdominal pain, diarrhea, and malnutrition. ### History/Background Cystic Fibrosis was first described in 1938 by Dr. Dorothy Andersen, an American pathologist who identified the condition as a distinct entity. However, the disease has been recognized for centuries, with descriptions of similar symptoms appearing in ancient medical texts. In the 1950s and 1960s, researchers began to identify the genetic basis of CF, and in 1989, the **CFTR gene** was cloned, paving the way for the development of genetic testing and targeted therapies. ### Key Information * **Symptoms:** Persistent coughing, wheezing, and shortness of breath, as well as digestive problems, such as abdominal pain, diarrhea, and malnutrition. * **Causes:** Mutations in the **CFTR gene**, which codes for a protein responsible for regulating the movement of salt and water in and out of cells. * **Complications:** Respiratory failure, digestive problems, malnutrition, and reproductive issues. * **Treatment:** Medications to thin mucus, antibiotics to treat infections, and lung transplantation in severe cases. * **Prognosis:** With proper treatment, individuals with CF can live into their 40s and 50s, but the disease remains a significant cause of morbidity and mortality. ### Significance Cystic Fibrosis is a significant public health concern, with over 75,000 people worldwide affected by the condition. The disease is a major cause of morbidity and mortality, particularly in children and young adults. However, advances in genetic testing, targeted therapies, and lung transplantation have improved the prognosis for individuals with CF, and researchers continue to explore new treatments and potential cures. **INFOBOX:** - Name: Cystic Fibrosis - Type: Genetic disorder - Date: 1938 (first described by Dr. Dorothy Andersen) - Location: Worldwide - Known For: Being a chronic, life-threatening disease affecting the respiratory, digestive, and reproductive systems. **TAGS:** Cystic Fibrosis, CFTR gene, genetic disorder, respiratory disease, digestive disease, reproductive disease, lung transplantation, genetic testing.
Health & MedicineConditions Encyclopedia Entry 1776407107
Cystic fibrosis is a chronic, genetic disorder that affects the respiratory, digestive, and reproductive systems, causing thick and sticky mucus to build up in the body's organs.
Health & MedicineConditions Encyclopedia Entry 1777024209
Cystic fibrosis (CF) is a genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and early death if left untreated.
Health & MedicineConditions Encyclopedia Entry 1777575017
Cystic fibrosis (CF) is a **genetic disorder** that affects the respiratory, digestive, and reproductive systems, causing severe damage and premature death if left untreated.
Health & MedicineConditions Encyclopedia Entry 1776544571
Cystic fibrosis (CF) is a chronic and progressive genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and potentially life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1776800524
Cystic fibrosis is a chronic, life-threatening genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and complications if left untreated.
Health & MedicineConditions Encyclopedia Entry 1777139884
Cystic fibrosis (CF) is a chronic, progressive genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and impairing the body's ability to function properly.
Health & MedicineConditions Encyclopedia Entry 1777663384
Cystic fibrosis is a chronic, genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage to the lungs, pancreas, and other organs.
Health & MedicineConditions Encyclopedia Entry 1775298066
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1777039338
Cystic fibrosis (CF) is a chronic, progressive genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and potentially life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1776913205
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1777230006
Mitochondrial myopathies are a group of rare genetic disorders affecting the mitochondria, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1776815413
** **Mitochondrial Myopathies** are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial Myopathies (MM) are a diverse group of disorders caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. These conditions affect the mitochondria's ability to produce adenosine triphosphate (ATP), the primary energy source for muscle cells. As a result, patients with MM experience muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the condition, and it is passed down from mother to child. Mitochondrial Myopathies are characterized by a range of symptoms, including muscle weakness, particularly in the proximal muscles (those closest to the trunk of the body), exercise intolerance, and fatigue. Some patients may also experience other systemic symptoms, such as cardiac conduction defects, hearing loss, and visual disturbances. The severity and progression of the condition can vary widely among individuals, and some patients may experience a gradual decline in muscle function over time. ## History/Background The first reported case of a mitochondrial myopathy was in 1962 by Dr. Hans Eiberg, a Danish physician who described a family with a rare disorder characterized by muscle weakness and exercise intolerance. Since then, numerous cases have been reported, and the condition has been recognized as a distinct entity within the field of neuromuscular disorders. In the 1980s, the discovery of the mitochondrial DNA and its role in energy production led to a greater understanding of the underlying mechanisms of MM. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can be inherited or acquired. The most common mutations associated with MM are in the mtDNA genes that encode for the respiratory chain complexes, particularly complex I, III, and IV. These mutations can lead to a reduction in ATP production, resulting in muscle weakness and fatigue. There are several types of Mitochondrial Myopathies, including: * **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by muscle weakness, exercise intolerance, and cardiac conduction defects. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by muscle weakness, seizures, and ragged-red fibers (a hallmark of mitochondrial myopathies). * **Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)**: a rare disorder characterized by muscle weakness, ataxia, and visual disturbances. ## Significance Mitochondrial Myopathies are a significant cause of muscle weakness and fatigue, particularly in young adults. Early diagnosis and treatment can help manage symptoms and improve quality of life. However, there is currently no cure for MM, and treatment is focused on managing symptoms and preventing complications. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Muscle weakness, fatigue, and other systemic symptoms ## Tags: Mitochondrial myopathies, genetic disorder, muscle weakness, fatigue, Kearns-Sayre syndrome, MERRF, NARP, mitochondrial DNA, respiratory chain complexes, ATP production. **Important Note:** If you or someone you know is experiencing symptoms of Mitochondrial Myopathies, it is essential to seek medical attention from a qualified healthcare professional. Early diagnosis and treatment can help manage symptoms and improve quality of life.
Health & MedicineConditions Encyclopedia Entry 1776841686
** This entry is about the medical condition known as **Cystic Fibrosis (CF)**, a genetic disorder that affects the respiratory, digestive, and reproductive systems. **CONTENT:** ## Overview Cystic Fibrosis (CF) is a chronic, progressive genetic disorder that affects the respiratory, digestive, and reproductive systems. It is caused by mutations in the **CFTR (Cystic Fibrosis Transmembrane Conductance Regulator)** gene, which codes for a protein responsible for regulating the movement of salt and water in and out of cells. In people with CF, the abnormal protein leads to the production of thick, sticky mucus that clogs the airways and digestive tract, causing a range of symptoms and complications. CF is one of the most common life-threatening genetic disorders, affecting approximately 70,000 people worldwide. CF affects people of all ages, from infants to adults, and is characterized by recurring respiratory infections, lung damage, and digestive problems. The symptoms of CF can vary in severity and may include persistent coughing, wheezing, and shortness of breath, as well as abdominal pain, diarrhea, and weight loss. If left untreated, CF can lead to respiratory failure, liver disease, and other complications. ## History/Background The first reported cases of CF date back to the 1930s, but it wasn't until the 1950s that the condition was recognized as a distinct genetic disorder. In the 1960s, researchers discovered that CF was caused by a defect in the **CFTR** gene, which was later identified as a chloride channel. The development of genetic testing in the 1980s allowed for the diagnosis of CF to be made earlier and more accurately. Today, CF is recognized as a global health issue, with research and treatment efforts focused on improving the quality of life for people with the condition. ## Key Information * **CFTR Gene:** The **CFTR** gene is responsible for producing a protein that regulates the movement of salt and water in and out of cells. * **Symptoms:** Recurring respiratory infections, lung damage, digestive problems, and other complications. * **Diagnosis:** Genetic testing, sweat test, and other diagnostic tests can help diagnose CF. * **Treatment:** Medications, such as **ivacaftor** and **lumacaftor**, can help manage symptoms and slow disease progression. * **Lung Transplant:** In severe cases, lung transplantation may be necessary to improve quality of life. ## Significance Cystic Fibrosis is a significant global health issue, affecting people of all ages and backgrounds. The condition has a profound impact on the lives of individuals with CF and their families, requiring ongoing medical care, therapy, and lifestyle adjustments. Research and treatment efforts are focused on improving the quality of life for people with CF, with a goal of developing more effective treatments and potentially a cure. **INFOBOX:** - Name: Cystic Fibrosis - Type: Genetic disorder - Date: 1930s (first reported cases) - Location: Global - Known For: Chronic respiratory and digestive complications **TAGS:** Cystic Fibrosis, CFTR gene, genetic disorder, respiratory disease, digestive disease, lung disease, genetic testing, treatment options, lung transplantation. **Note:** If you or a loved one has been diagnosed with Cystic Fibrosis, it's essential to work with a healthcare team to develop a personalized treatment plan. Early diagnosis and treatment can significantly improve quality of life and outcomes.
Health & MedicineConditions Encyclopedia Entry 1775387525
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA. These disorders affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. MMs are characterized by their unique inheritance pattern, as they are passed down from mother to child through the mitochondria. This condition is often associated with **mitochondrial dysfunction**, which can lead to a range of symptoms, including muscle pain, weakness, and fatigue. Mitochondrial Myopathies are a complex group of disorders, with over 150 different mutations identified in the mitochondrial DNA. The symptoms of MMs can vary widely, depending on the specific mutation and the individual affected. Some people may experience mild symptoms, while others may have more severe symptoms that affect their daily lives. In some cases, MMs can lead to life-threatening complications, such as heart failure or respiratory failure. ### History/Background The first descriptions of MMs date back to the 1960s, when researchers began to identify cases of mitochondrial myopathies in families. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of researchers identified the first mitochondrial DNA mutation associated with a mitochondrial myopathy. Since then, numerous studies have been conducted to better understand the genetics and pathophysiology of MMs. ### Key Information * **Prevalence:** Mitochondrial Myopathies are rare, affecting approximately 1 in 5,000 people worldwide. * **Inheritance:** MMs are inherited in a maternal lineage, meaning they are passed down from mother to child through the mitochondria. * **Symptoms:** Symptoms of MMs can include muscle weakness, fatigue, muscle pain, and other systemic symptoms. * **Diagnosis:** Diagnosis of MMs typically involves a combination of genetic testing, muscle biopsy, and imaging studies. * **Treatment:** There is currently no cure for MMs, but treatment options are available to manage symptoms and improve quality of life. ### Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. MMs also underscore the need for further research into the genetics and pathophysiology of these disorders. Additionally, MMs have significant implications for families affected by these disorders, as they can have a profound impact on quality of life and family dynamics. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** First described in the 1960s - **Location:** Worldwide - **Known For:** Unique inheritance pattern and mitochondrial dysfunction **TAGS:** Mitochondrial dysfunction, genetic disorder, rare disease, muscle weakness, fatigue, muscle pain, mitochondrial DNA, maternal inheritance, genetic testing, muscle biopsy, imaging studies, treatment options, quality of life, family dynamics. **When to Seek Professional Care:** If you or a family member is experiencing symptoms of Mitochondrial Myopathies, it is essential to seek medical attention from a qualified healthcare professional. Early diagnosis and treatment can significantly improve quality of life and manage symptoms. If you have a family history of MMs or are concerned about your risk, consult with a genetic counselor or a healthcare professional for guidance.
Health & MedicineConditions Encyclopedia Entry 1776445445
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation, which is not inherited from either parent. The diagnosis of mitochondrial myopathies can be challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background Mitochondrial myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of researchers led by Dr. Douglas C. Wallace identified the first mitochondrial DNA mutation associated with a mitochondrial myopathy. Since then, numerous other mutations have been identified, and the genetic basis of these disorders has been extensively studied. ## Key Information Mitochondrial myopathies are a diverse group of disorders, and the specific symptoms and characteristics can vary widely. Some common features of these disorders include: * **Muscle weakness**: Mitochondrial myopathies can cause progressive muscle weakness, particularly in the muscles of the face, arms, and legs. * **Fatigue**: Patients with mitochondrial myopathies often experience fatigue, which can be severe and debilitating. * **Other systemic problems**: Mitochondrial myopathies can also cause a range of other systemic problems, including heart disease, diabetes, and neurological disorders. * **Genetic inheritance**: Mitochondrial myopathies are often inherited in an autosomal dominant or maternal inheritance pattern. * **Genetic testing**: Genetic testing can be used to diagnose mitochondrial myopathies, but it is not always possible to predict the severity of the disorder. ## Significance Mitochondrial myopathies are a significant public health concern, as they can have a major impact on the quality of life of affected individuals. These disorders are often associated with a high degree of disability and mortality, and there is currently no cure. However, research into the genetic basis of these disorders has led to the development of new treatments and therapies, which can help to manage the symptoms and slow the progression of the disorder. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first described) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, fatigue, and other systemic problems TAGS: Mitochondrial myopathies, genetic disorder, muscle weakness, fatigue, autosomal dominant inheritance, maternal inheritance, genetic testing, mitochondrial DNA, muscle biopsy.
Health & MedicineConditions Encyclopedia Entry 1776503465
** This entry is about the condition known as **Ehlers-Danlos Syndrome (EDS)**, a group of genetic disorders that affect the body's connective tissue. ## Overview Ehlers-Danlos Syndrome (EDS) is a rare genetic disorder characterized by extremely flexible joints, skin hyperextensibility, and tissue fragility. It affects approximately 1 in 5,000 to 1 in 20,000 people worldwide. EDS is often misunderstood, and its symptoms can vary greatly from person to person, making diagnosis challenging. The condition is named after the two doctors who first described it, Edvard Ehlers and Henri-Alexandre Danlos. People with EDS may experience a range of symptoms, including joint instability, easy bruising, and poor wound healing. They may also have a higher risk of developing other conditions, such as gastrointestinal problems, cardiovascular issues, and osteoporosis. While EDS is primarily a genetic disorder, environmental factors can also contribute to its development. ## History/Background The first reported case of EDS was in 1892 by the Danish dermatologist Edvard Ehlers. He described a patient with extremely flexible joints and fragile skin. Later, in 1908, the French dermatologist Henri-Alexandre Danlos wrote a paper about a similar condition, which he called "cutis hyperelastica." The two doctors' work laid the foundation for the understanding of EDS as a distinct medical condition. Over the years, researchers have identified several subtypes of EDS, each with its unique set of symptoms and characteristics. The most common subtypes are Classical EDS (cEDS), Hypermobile EDS (hEDS), and Vascular EDS (vEDS). While the exact cause of EDS is still not fully understood, it is believed to result from mutations in genes that code for collagen, a protein essential for connective tissue. ## Key Information EDS is a complex condition that affects various aspects of a person's life. Some key facts about EDS include: * **Genetic inheritance**: EDS is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. * **Symptom variability**: The severity and type of symptoms can vary greatly from person to person, even within the same family. * **Diagnostic challenges**: EDS can be difficult to diagnose, as its symptoms are often similar to those of other conditions. * **Comorbidities**: People with EDS are at a higher risk of developing other conditions, such as gastrointestinal problems, cardiovascular issues, and osteoporosis. * **Treatment options**: While there is no cure for EDS, various treatments can help manage its symptoms, including physical therapy, pain management, and surgery. ## Significance EDS is a significant condition that affects not only the individual but also their family and caregivers. Understanding EDS is crucial for providing proper care and support to those affected. Some of the reasons why EDS matters include: * **Improved diagnosis**: Accurate diagnosis and early intervention can significantly improve the quality of life for people with EDS. * **Increased awareness**: Raising awareness about EDS can help reduce stigma and promote understanding among healthcare professionals and the general public. * **Advancements in research**: Continued research into EDS can lead to a better understanding of its causes and development of new treatments. INFOBOX: - **Name:** Ehlers-Danlos Syndrome (EDS) - **Type:** Genetic disorder - **Date:** 1892 (first reported case) - **Location:** Worldwide - **Known For:** Extremely flexible joints, skin hyperextensibility, and tissue fragility TAGS: Ehlers-Danlos Syndrome, genetic disorder, connective tissue, joint instability, skin hyperextensibility, tissue fragility, gastrointestinal problems, cardiovascular issues, osteoporosis, rare condition.